Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
100.00%
Operating Margin
60.39%
Net Margin
33.20%
Efficiency Metrics
Revenue per Expense Ratio
2.52
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
0.00%
Income Tax Rate
0.00%
EPS
0.6000000000
Balance Sheet Analysis
Current Ratio
0.06
Cash Ratio
0.05
Working Capital
$-285.38M
Debt to Equity
18.88
Debt to Assets
93.44%
Equity Ratio
4.95%
Cash Flow Analysis
Operating Cash Flow Ratio
74.97%
Free Cash Flow Ratio
70.66%
CapEx to Revenue
4.31%
Dividends Paid
$51.45M
Stock Buybacks
$80.00K
Total Shareholder Returns
$51.53M
Cash Position Change
-18.17%
Key Takeaways (2023 FY)
Increased dividend payments by 32.46%
Detailed Growth Metrics
Core Performance
Revenue
211.39%
Net Income
-75.78%
EPS
-84.73%
Operating Income
21.97%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
-11.45%
Operating Cash Flow
-52.04%
Free Cash Flow
-52.04%
Balance Sheet Health
Assets
-13.93%
Debt
-9.71%
Book Value per Share
-30.20%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
32.46%
Shares Outstanding
17.11%
Long Term Trends
3Y Revenue/Share
-34.64%
5Y Revenue/Share
-64.29%
3Y Dividend/Share
111.12%
5Y Dividend/Share
0.00%